Carboplatin/paclitaxelHepatitis B virus reactivation: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1643卷 / 1期

关键词：

D O I：

10.1007/s40278-017-27542-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：69 / 69

相关论文

共 50 条

[1] Cyclophosphamide/doxorubicin/paclitaxelHepatitis B reactivation: case report
Reactions Weekly, 2023, 1969 (1) : 134 - 134
[2] Carboplatin/mogamulizumabHepatitis B virus reactivation (first report with mogamulizumab): case report
Reactions Weekly, 2014, 1495 (1) : 14 - 14
[3] Carboplatin/cisplatinOtotoxicity and fatal hepatitis B reactivation: case report
Reactions Weekly, 2020, 1830 (1) : 105 - 105
[4] RituximabHepatitis B virus reactivation: case report
Reactions Weekly, 2018, 1706 (1) : 439 - 439
[5] OcrelizumabHepatitis B virus reactivation: case report
Reactions Weekly, 2019, 1745 (1) : 208 - 208
[6] PrednisoloneHepatitis B virus reactivation: case report
Reactions Weekly, 2023, 1946 (1) : 472 - 472
[7] RituximabHepatitis B virus reactivation: case report
Reactions Weekly, 2008, 1199 (1) : 40 - 40
[8] RuxolitinibHepatitis B virus reactivation: case report
Reactions Weekly, 2021, 1850 (1) : 257 - 257
[9] RituximabHepatitis B virus reactivation: case report
Reactions Weekly, 2018, 1709 (1) : 223 - 223
[10] RituximabHepatitis B virus reactivation: case report
Reactions Weekly, 2022, 1923 (1) : 436 - 436

← 1 2 3 4 5 →